There is also evidence for the ability of NLRP3 signaling to contribute to the establishment of an immunosuppressive microenvironment in pancreatic cancer by promoting T cells to undergo tolerogenic differentiation and through the IL-10-mediated suppression of adaptive immunity [29]. The gene discussed is IL10; the disease is familial pancreatic carcinoma.